济民健康管理股份有限公司关于以集中竞价交易方式回购股份的进展公告

Group 1 - The company has approved a share repurchase plan using its own funds and bank loans, with a maximum repurchase price of RMB 10 per share and a total repurchase amount between RMB 100 million and RMB 200 million, with a duration of up to 12 months from the board's approval date [1] Group 2 - As of August 31, 2025, the company has repurchased a total of 2,005,500 shares, accounting for 0.3819% of the total share capital, with a maximum purchase price of RMB 6.13 per share and a minimum price of RMB 5.87 per share, totaling RMB 12,088,967.50 spent (excluding transaction fees) [2] Group 3 - The company will adhere to relevant regulations and make repurchase decisions based on market conditions, ensuring timely information disclosure regarding the progress of the share repurchase [3]